Since a basic surface on the catalytic (C) subunit of cAMP-dependent protein kinase is important for binding to the regulatory (R) subunit, acidic residues in R were sought that might contribute to R-C interaction. Using differential labeling by a water-soluble carbodiimide (Buechler, T. A., and Taylor, S. S. (1990) Biochemistry 29, 1937-1943), seven specific carboxylates in RI␣ were identified that were protected from chemical modification in the holoenzyme; each was then replaced with Ala. Of these, rRI(E15A/E106A/D107A)), rRI(E105A), rRI(D140A), rRI(E143A), and rRI(D258A) all were defective in holoenzyme formation and define negative electrostatic surfaces on RI␣. An additional conserved carboxylate, Glu 101 in RI␣ and the equivalent, Glu 99 in RII␣ were mutated to Ala. Replacement of Glu 101 had no effect while rRII(E99A) was very defective. RI␣ and RII␣ thus differ in the molecular details of how they recognize C. Unlike wild-type RI, two additional mutants, rRI(D170A) and rRI(K242A), inhibited C-subunit stoichiometrically in the presence of cAMP and show increases in both on-and off-rates. Asp 170 , which contributes directly to the hydrogen bonding network in cAMPbinding site A, thus contributes also to holoenzyme stability.
exists as an inactive tetramer (R 2 C 2 ) that dissociates in the presence of cAMP to release two active catalytic (C) subunits and a dimeric regulatory (R) subunit saturated with four molecules of cAMP (R 2 -cAMP 4 ). The two classes of cAPK, type I and type II, differ primarily in their regulatory subunits (1) . The two known families of physiological inhibitors of cAPK, the regulatory subunits (RI and RII) and the heat-stable protein kinase inhibitor (PKI) employ a common mechanism for the inhibition of C. Each inhibitor has an autoinhibitory domain that resembles the substrate consensus sequence, "RRXS/T⌿," where X is any amino acid, and the Pϩ1 site is a hydrophobic group (⌿). In RII the P-site is a Ser, while in RI and PKI, this site is an Ala (2) (3) (4) .
Although binding of this autoinhibitor region to the active site of C is essential for inhibition, this interaction alone is not sufficient for high affinity binding. The R-subunits, as well as PKI, bind to C with K d values that lie in the subnanomolar range (5-7), while peptides containing only the autoinhibitor site bind with micromolar affinity (8, 9) . Furthermore, mutant forms of RI and RII with Ala substitutions at the P-2 and P-3 arginines can still form stable holoenzyme complexes in the absence of cAMP (10, 11) , indicating that there are additional regions of interaction between R and C that lie beyond the autoinhibitor site. These sites are referred to here as peripheral sites.
As shown in Fig. 1 , the R-subunit has a well defined domain structure consisting of an N-terminal dimerization domain, followed by the autoinhibitory region and two tandem cAMPbinding domains, A and B. Proteolytic cleavage of the RIIsubunit at a site just prior to the P-3 Arg yielded a monomeric R-subunit fragment that still bound C with high affinity (12) indicating that the sites of interaction that contribute to high affinity binding lie C-terminal to the autoinhibitor consensus sequence. This is in striking contrast to PKI, whose highaffinity binding determinants lie mostly N-terminal to the consensus site (7, 9) . Furthermore, deletion mutations that removed the N terminus (⌬1-91) or the B-domain (⌬260 -379) or combined mutations that removed both the N terminus and the B-domain, also did not prevent high affinity binding to C (13, 14) . The high affinity binding sites are thus localized between the consensus site and the end of the A-domain (Fig. 1) .
When the crystal structure of the C-subunit (15) and, more recently, a deletion mutant of the R-subunit (16) were solved, these structures provided major insights into the docking surfaces that might be important for interactions between the C-subunit and its inhibitors. The peripheral PKI site, referred to here as peripheral recognition site 1 (PRS1), was originally mapped with peptide analogs (9) , and is defined in the crystal structure of the catalytic subunit bound to the inhibitor peptide, PKI(5-24) (17) . An additional surface on the C-subunit, referred to here as peripheral recognition site 2 (PRS2), was predicted based on genetic mapping, to be important for Rsubunit binding (18 -21) . In contrast to the acidic surface on C where the consensus site peptide and PKI bind, the PRS2 surface importance for binding to R is very basic. This led us to search for acidic residues in R that might complement C. The deletion analysis described above limited the search for acidic residues to the region between the inhibition site and the beginning of domain B.
To chemically identify potential sites on the RI-subunit involved in R-C interaction, type I holoenzyme was treated with the water-soluble carbodiimide, 1-ethyl-3(3-dimethyl-aminopropyl)-carbodiimide⅐HCl (EDC), and [
14 C]glycine ethyl ester in the absence and presence of cAMP (22 2 To clarify the potential importance of these residues for R-C interaction, each was replaced with Ala. The mutant R-subunits were then purified and tested for their ability to inhibit C.
Several additional sites were tested. The highly conserved glutamic acid residue 150 (Glu 101 in RI), when mutated to Ala in BCY1, the yeast regulatory subunit, led to defective recognition of C (TPK1). 3 This site was therefore mutated to Ala in RI and RII to establish whether this residue was also important for R-C interaction in the mammalian holoenzymes.
Two additional charge-to-Ala mutations, D170A and K242A, were made in the RI subunit based on their location in the crystal structure of (⌬1-91)RI (16) . Asp 170 , a highly conserved residue, lies on ␤-strand 3 of the A-domain where it forms a hydrogen bond with Arg 209 , a key residue in the cAMP-binding site (16, 23) . The overall charge of the A-domain is acidic, however, there is a basic patch on the C-helix associated with Lys 242 . Lys 242 was therefore targeted as a potential electrostatic interaction site in the holoenzyme complex.
EXPERIMENTAL PROCEDURES
Materials-Reagents were obtained from the following sources: phosphoenolpyruvate, magnesium chloride, reduced nicotinamide adenine dinucleotide (NADH), MES, MOPS, Tris, pyruvate kinase (rabbit muscle), and lactate dehydrogenase (bovine heart), Sigma; restriction endonucleases, T4 ligase, T7 polymerase, U. S. Biochemical Corp. or Life Technologies, Inc.; radioactive nucleotides, Amersham or NEN Life Science Products; and media supplies, Difco. The peptide substrate, LRRASLG, was synthesized at the Peptide Facility at the University of California, San Diego. Oligonucleotides were synthesized using an Applied Biosystem DNA synthesizer, Model 380B. The following bacterial strains were used: Escherichia coli DH5␣, E. coli JM101 (ATCC), E. coli BL21-DE3 (gift from William Studier of Brookhaven National Laboratories, Upton, NY), and E. coli E222. The following vectors were used: phagemid pUC119 (ATCC), PLWS-3 (24), and PRSET-B (Invitrogen).
Mutagenesis-Mutations in the R-and C-subunits were introduced as described by Kunkel (25) , and Asp 107 , were changed to Ala (E105A/E106A/D107A). The mutant recombinant regulatory subunits, rRI(E101A), rRI(EED/AAA), rRI(E105A), rRI(E106A), rRI(D107A), rRI(D140A), rRI(E143A), rRI(E255A), rRI(D258A), rRI(D170A), and rRI(K242A), were expressed in E. coli 222 as described previously (27) . The residue corresponding to Glu 101 (Glu 99 ) was mutated to Ala using a PRSET-B vector containing the RII gene fused to a polyhistidine (His 6 ) tag.
Protein Purification-The recombinant murine C-subunit was purified from E. coli as described (24, 28) . Isoform II was used for all of the following experiments. Wild-type and mutant RI-subunits were purified using anion exchange chromatography (DE52) as described previously (29) . Pooled fractions from the DE52 column were precipitated with ammonium sulfate and further purified by FPLC gel filtration on a Superdex 200 column (Pharmacia). Concentration and purity of the RI-subunits were determined by absorbance at 280 nm using an extinction coefficient of 1.0. All RI-subunits were at least 95% pure based on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and analytical gel filtration.
H 6 -RII(WT) and H 6 RII(E99A) were expressed in E. coli BL21-DE3 (4L) by inducing with isopropyl-1-thio-␤-D-galactopyranoside for 5 h at 37°C. Cells were harvested and lysed twice in a French pressure cell in 40 ml of lysis buffer (50 mM potassium phosphate, pH 8.0, 300 mM NaCl, 5 mM ␤-ME, 10 mM benzamidine, 1 M leupeptin, 70 g/ml L-1-tosylamido-2-phenylethyl chloromethyl ketone, 37 g/ml N ␣ -p-tosyl-L-lysine chloromethyl ketone, 0.5 mM phenylmethylsulfonyl fluoride). Cell lysates were centrifuged for 40 min at 15,000 rpm. Supernatant factions were batch bound to 10 ml of Ni 2ϩ resin (Quiagen) for 15 min at 4°C. Resin was washed twice with 20 ml of lysis buffer, twice with 20 ml of 20 mM imidazole, and twice with 20 ml of 50 mM imidazole. The protein was eluted with 100 mM imidazole (100 ml) and collected in 5-ml fractions. The peak containing R-subunit was pooled and dialyzed against 2 liters of (20 mM Tris, 150 mM NaCl, 5 mM ␤-ME, pH 7.3) for 5 h and then overnight against 2 liters (20 mM Tris, 20 mM NaCl, 5 mM ␤-ME, pH 7.3). The dialyzed sample was then loaded onto a Mono Q column in Buffer A (20 mM Tris, 5 mM ␤-ME, pH 7.3) and eluted with a linear gradient from 0 to 300 mM potassium phosphate, pH 7. con) prior to addition of glycerol (final concentration, 30%) and stored at Ϫ20°C. To obtain cAMP-free R-subunit, the R-subunits were unfolded with 8 M urea, dialyzed, and then purified by gel filtration as described by Buechler et al. (10) .
Kinase Assay-Kinase activity was measured spectrophotometrically using the heptapeptide substrate, LRRASLG (Kemptide), and a coupled enzyme assay (30) . The concentration of C in the assay was between 20 and 60 nM. Holoenzyme samples were assayed first in the absence and then in the presence of 100 M cAMP to obtain a ratio of activity representing the amount of free C in the mixture.
Holoenzyme Formation-cAMP-saturated native RI subunit (3 M) and C-subunit (2 M) were combined (0.8 ml) and dialyzed in a multiwell dialysis chamber against buffer B (25 mM potassium phosphate, 100 M ATP, 500 M MgCl 2 , 5% glycerol, 5 mM ␤-ME, pH 6.5) at 22°C. Aliquots (30 l) were removed at the indicated times and assayed for catalytic activity. The H 6 RII holoenzyme was formed at 4°C in buffer C (25 mM potassium phosphate, pH 6.5, 5% glycerol, 5 mM ␤-ME, 0.1 mM EDTA, 0.1 mM EGTA) to minimize breakdown of the H 6 RII-subunit. Dialysis experiments were typically carried out in duplicate and were highly reproducible. As an alternative method for measuring holoenzyme formation, the activity of 20 nM C-subunit was titrated directly in the spectrophotometric assay by the addition of increasing amounts of R-subunit that had been stripped of cAMP by urea.
Tryptophan Fluorescence-R-subunit was dialyzed overnight against 1 liter of buffer D (5 mM MOPS, pH 7.0, 0.5 mM EDTA, 100 mM KCl, 5 mM ␤-ME) and against an additional 1 liter for 4 h to remove free cAMP. Fluorescence measurements were made using 1 ml of 0.2 M R-subunit in a 1-cm quartz cuvette at 23°C and a SLM Aminco SPF-500 spectrofluorimeter interfaced with a PC/AT computer. The excitation wavelength was 290 nm with a bandpass of 10 nm. The excited samples were scanned for tryptophan fluorescence from 300 to 450 nm using an emission bandpass of 5 nm. Spectra were analyzed using Spectra-Calc software. For the cAMP titrations, urea-stripped RI-subunit (50 nM) was incubated in buffer E (20 mM MOPS, 150 mM KCl, 5 mM ␤-ME, pH 7.0) with increasing concentrations of cAMP (0 -100 M) as described by León and Taylor. 4 The excitation wavelength was 295 nm and the emission was measured at 347 nm.
Apparent Activation Constants (K a ) for cAMP-Apparent activation constants, K a (cAMP), were determined according to Herberg et al. (32) . Wild-type and mutant holoenzymes were prepared with 1.2 M Csubunit and 1.0 M R-subunit by dialysis overnight at room temperature against buffer F (20 mM potassium phosphate, 100 mM KCl, 5 mM ␤-ME, 5% glycerol, 100 M ATP, 1 mM MgCl 2 , pH 6.5). Holoenzyme (30 nM) was incubated for 5 min at room temperature with cAMP (1-180 M) in 1 ml of assay mixture prior to the addition of Kemptide substrate. Activity was then measured using the spectrophotometric assay.
Analytical Gel Filtration-The Stokes radius was determined using an FPLC Superdex 200 column as described previously (28) . The column was equilibrated with (20 mM MOPS, 150 mM KCl, 5 mM ␤-ME, pH 7.0) and run with a flow rate of 0.8 ml/min.
Surface Plasmon Resonance-Surface plasmon resonance was used to study the interaction between the rC subunit and the rR subunits of cAPK using a BIAcore instrument (Pharmacia/Biosensor) (33) . The C-subunit was coupled to a sensor chip by direct amine coupling to the CM dextran surface (Biosensor Amine Coupling Kit) as described previously (32) .
Kinetic constants were calculated using the BIAcore pseudo-first order rate equation,
where k ass is the association rate, k dis is the dissociation rate, C is the concentration of the injected analyte, and R is the response. Plots of dR/dt versus Rt have a slope of k s . When k s is plotted against C the resulting slope is equal to the k ass . The dissociation rate, k dis , was calculated by integrating the rate equation when C ϭ 0, yielding ln(Rt 1 / Rt n ) ϭ k dis (tn Ϫ t 1 ). Affinity constants were calculated from the equation
All binding interactions were performed at 23°C in 20 mM MOPS, 150 mM KCl, 100 M ATP, 1 mM MgCl 2 , 0.5 mM dithiothreitol, 0.005% P20, pH 7.0. After injections of the rR subunits the rC subunit surface was regenerated by injection of 10 l of 10 M cAMP. Association rate calculations were performed using concentrations between 30 and 500 nM for rRI(WT), rRI(D170A), and rRI(K242A). All of the rR-subunits were stripped of cAMP prior to injection.
RESULTS
To characterize the importance of various charged residues in the R-subunit for recognition of C and formation of holoenzyme, the following charge to Ala mutations were engineered: E101A, E105A/E106A/D107A, E105A, E106A, D107A, D140A, E143A, E255A, D258A, D170A, K242A in RI and E99A in RII (Table I) . Each mutant RI-subunit was expressed in E. coli and purified as described under "Experimental Procedures." The proteins were typically at least 80% pure following DE52 anion exchange chromatography and eluted as a sharp peak from the Superdex 200 gel filtration column. Typical yields were 40 -50 mg of RI-subunit per 4 liters of cells. All of the purified RIsubunits were greater than 95% pure as judged by SDS-PAGE.
The poly-His-tagged RII-subunits, H 6 RII(WT) and H 6 RII(E99A), were purified from Ni 2ϩ resin by batch elution with imidazole. H 6 RII(E99A) was greater than 95% pure following FPLC Mono Q chromatography; however, degradation occurred upon long-term storage (Ͼ6 months) at Ϫ20°C. , and rRI(D107A) with wild-type C-subunit. Wild-type (q) and mutant RI-subunits: RI(EED/AAA) (f), RI(E105A) (å), RI(E106A) (ࡗ), and RI(D107A) (ç) were dialyzed in the presence of wild-type C-subunit as described under "Experimental Procedures." % Activity is the ratio of catalytic activity remaining in the dialysis mixture in the absence or presence of 100 M cAMP and represents the amount of free C remaining in the mixture at the times indicated. These dialysis were all carried out simultaneously and were highly reproducible with multiple preparations of the proteins. Duplicates were typically within 5%. acidic patch just after the autoinhibitor site and conserved in all R-subunits was protected against modification by EDC when the RI subunit was associated with C. 2 To test whether specific contacts involving Glu 105 -Glu 106 -Asp 107 were important for interactions between the R-and C-subunits, each carboxylate was replaced with Ala, generating the following mutants: rRI(E105A), rRI(E106A), and rRI(D107A). In addition, the triple mutant, rRI(E105A/E106A/D107A), was made.
The purified RI-subunits were combined with purified recombinant murine C-subunit, rC(WT), in a multiwelled microdialysis chamber and the relative rates of holoenzyme formation of the mutant RI-subunits were compared with that of wild-type RI as described under "Experimental Procedures." The dialysis curves in Fig. 2 indicated that the triple mutant, rRI(EED/AAA), formed 40% holoenzyme after 10 h of dialysis at room temperature, while, after the same length of time, 90% of the wild-type control had formed holoenzyme. The single mutant, rRI(E105A), exhibited a slight defect in holoenzyme formation while the other two single-site mutations, rRI(E106A) and rRI(D107A), were indistinguishable from the wild-type control. , four other acidic residues in the RI-subunit were protected from chemical modification in the presence of C.
2 These sites included two residues at the beginning of the A-domain (Asp 140 and Glu
143
) and two at the end of the A-domain (Glu  255 and Asp   258 ). To test whether any of these sites were involved in a direct interaction with C, each was mutated to Ala, and the purified mutant proteins were paired with wild-type C in the holoenzyme dialysis assay. As shown in Fig. 3 (A and B) , three of the mutants, rRI(D140A), rRI(E143A), and rRI(D258A), showed similar defects in their rates of holoenzyme formation. After 10 h of dialysis at room temperature, these mutant RI-subunits inhibited only 60% of the C-subunit activity, while the wild-type control was more than 90% inhibited, indicating that Asp was not modified by EDC in either the cAMP-bound form of RI or in the type I holoenzyme, it is highly conserved in all regulatory subunits. Furthermore, mutation of this site to Ala in BCY1, the yeast regulatory subunit, abolished the ability of BCY1 to inhibit the yeast C-subunit, TPK1. 3 As shown in Fig. 3C , however, mutation of this site to Ala in the RI-subunit had no affect on the rate of holoenzyme formation compared with RI-WT.
Since BCY1 is a type II R-subunit, the equivalent mutation was also made in the mammalian RII-subunit, RII(E99A), to determine if this site was important for R-C interaction in the type II holoenzyme. Activity assays of the holoenzyme mixtures following 17 h of dialysis indicated that, unlike the wild-type control, which was 95% inhibited, H 6 RII(E99A) only showed 20% inhibition (Fig. 3D) . Following dialysis, SDS-PAGE of the holoenzyme mixtures verified that the lack of holoenzyme formation observed for H 6 RII(E99A) was not due to proteolysis of the RII-subunit. The fact that Glu 101 is important for holoenzyme formation with RII and BCY1 but not for RI, even though this residue is conserved, indicates that the interaction sites between R and C in the type I and type II holoenzymes that lie beyond the autoinhibitor region differ in their molecular details.
The Effect of Mutating Asp 170 in the A-Domain of RI-Asp

170
is another acidic residue that is conserved among the regulatory subunits of the cAPK family (34) . It lies in cAMP-binding domain A where it forms a hydrogen bond with Arg 209 , a residue that is absolutely conserved among the cAMP-binding domains of the regulatory subunits and the catabolite gene activator protein (16, 23 The wild-type RI␣-subunit binds cAMP very tightly, so that the purified R-subunit is always fully saturated with cAMP. Thus, under the conditions used for holoenzyme formation where C, R, and cAMP are present at relative concentrations of 1:1:2, wild-type RI does not linearly titrate the activity of the C-subunit. Linear and stoichiometric titration is achieved only when cAMP is stripped from R prior to reassociation with C. Otherwise, dialysis is required to remove the cAMP. In contrast to wild-type RI, when rRI(D170A) was added to the C-subunit, inactivation was immediate; rRI(D170A) behaved similarly to R-subunit that had been stripped of cAMP with urea. rRI(D170A) was then tested for its ability to titrate the catalytic activity directly in the spectrophotometric assay. The inhibition assay measured the following reaction,
where loss of activity correlates with the formation of the R 2 C 2 complex. As shown in Fig. 4 , when rRI(D170A) was added directly to the assay mixture where the C-subunit concentration was 20 nM, inhibition of catalytic activity was linear and stoichiometric. This was in striking contrast to the inhibition of C with wild-type RI which must be stripped of cAMP before stoichiometric inhibition can be achieved under these conditions. The linear and stoichiometric inhibition of C with rRI(D170A) indicated not only that the K d for this mutant R and rC(WT) was well below 20 nM, but also, under these conditions, rRI(D170A) had a higher affinity for C than for cAMP, causing the equilibrium of reaction (2) to lie to the right. Several factors could account for this. The affinity for cAMP could be reduced so that the purified rRI(D170A) was not saturated with cAMP. Alternatively, the affinity for C could be increased. To resolve these possibilities, the cAMP binding properties of rRI(D170A) were characterized more fully. cAMP Binding Properties of rRI(D170A) and rRI(D170A) 2 C 2 -One explanation for the above observations would be that mutation of Asp-170 interferes with the high affinity binding of cAMP. Other mutations in the R-subunit that specifically disrupt cAMP binding in either the A-or B-domain such as rRI(R209K) or rRI(R333K) also inhibit C linearly and stoichiometrically without having to first remove cAMP (6) . When purified, only one cAMP-binding site is occupied in these mutant R-subunits and these proteins behave like stripped rRI(WT). Unlike rRI(WT), rRI(R209K) and rRI(R333K) form stable holoenzyme complexes even when cAMP levels are high.
The intrinsic tryptophan fluorescence of the RI-subunit is quenched by cAMP (29, 35) . Since the B-domain of RI does not have any tryptophans, the change in tryptophan fluorescence in response to cAMP is a sensitive method for measuring cAMP binding to the A-domain. For example, the intrinsic tryptophan fluorescence of wild-type RI is quenched compared with that of RI(R209K) because no cAMP is bound to site A in RI(R209K). 4 The fluorescence spectrum of rRI(D170A) compared with rRI(WT) and rRI(R209K) is shown in Fig. 5 . The spectrum of rRI(D170A) was similar to that of the wild-type RI-subunit and showed significant quenching compared with rRI(R209K). Thus cAMP was bound to the A-domain of rRI(D170A), similar to RI(WT) and in contrast to the rRI(R209K) where the A site is not occupied by cAMP. To confirm this, an apparent K d for cAMP binding was obtained by titrating the tryptophan fluorescence of the urea stripped proteins with increasing amounts of cAMP. As seen in Fig. 5 (inset) , the apparent K d for cAMP binding to rRI(D170A) (K d ϭ 62 nM) was similar to that of rRI(WT) (K d ϭ 45 nM) and was comparable to the K d measured by equilibrium dialysis (36) .
To further characterize the cAMP binding properties of rRI(D170A), the apparent K a for cAMP activation of the mutant holoenzyme was measured. The K a for cAMP activation of rRI(D170A) was 127 nM which correlates well with 88 nM for wild-type holoenzyme. This is also similar to the previously reported K a for wild-type holoenzyme (6) . In contrast, the K a for cAMP activation of RI(R209K) was 1700 nM (6) .
Stokes Radius-The Stokes radius of rRI(D170A) was measured to determine whether the mutation had altered the global structure of RI. The native form of rRI(D170A) had a Stokes radius of 46.1 Å, similar to that of native RI (32) . Furthermore, the urea-stripped cAMP-free form of rRI(D170A) had a Stokes radius that was 1.3 Å smaller than the native, cAMP-bound form. This is also similar to the wild-type protein which exhibited a 2-Å decrease in Stokes radius upon removal of cAMP (32) . In contrast, RI(R209K), which is defective in binding cAMP to the A-domain, has a Stokes radius that is similar to the cAMP-free form of RI(WT) (32) .
The Effect of Mutating Lys 242 -To establish whether Lys 242 in RI contributed to the high affinity binding between R and C, the mutant protein, rRI(K242A), was tested for its ability to inhibit wild-type C. Surprisingly, like the D170A mutant, inhibition of rC(WT) with rRI(K242A) did not require dialysis. rRI(K242A) also inhibited 20 nM rC(WT) in the spectrophotometric assay in a linear and stoichiometric fashion without being stripped of cAMP. This mutation also did not appear to affect cAMP binding, since the apparent K a of cAMP activation of the rRI(K242A) mutant holoenzyme was similar to that of wild-type holoenzyme. FIG. 5 . Tryptophan fluorescence of rRI(D170A), rRI(R209K), and rRI(WT). RI-subunit (0.2 M) was dialyzed against (5 mM MOPS, pH 7.0, 0.5 mM EDTA, 100 mM KCl, 5 mM ␤-ME) to remove free cAMP. Fluorescence measurements were made as described under "Experimental Procedures." The excitation wavelength was 290 nm with a bandpass of 10 nm. The excited samples were scanned for tryptophan fluorescence from 300 to 450 nm using an emission bandpass of 5 nm. Spectra were analyzed using Spectra-Calc software. Inset, the tryptophan fluorescence of urea stripped rRI(WT) (q) and rRI(D170A) (f) was titrated by the addition of increasing amounts of cAMP as described under "Experimental Procedures." The % quench was plotted against the log[cAMP] to obtain apparent K d values for cAMP binding. The fluorescence titration of rRI(WT) is carried out routinely and is highly reproducible. The mutant was characterized on two separate occasions.
Surface Plasmon Resonance-One explanation for the ability of rRI(D170A) and rRI(K242A) to stoichiometrically inhibit C without first removing cAMP is that the mutations increased the affinity of RI for C. Surface plasmon resonance was used to quantitate the affinity of these mutant R-subunits for C. Using a BIAcore instrument (Pharmacia), cAMP-free rRI(D170A) and rRI(K242A) were applied to a chip containing immobilized wild-type C-subunit. R/C binding was measured by monitoring changes in the refractive index on the surface of the chip, allowing real-time binding kinetics to be measured. The results using rRI(D170A) and rRI(K242A) are compared with rR(WT) in Fig. 6 . Both the on-and off-rates are monophasic for all three proteins. As summarized in Table II , although the overall binding affinities of rRI(D170A) and rRI(K242A) were similar to rRI(WT), rRI(D170A) exhibited on-and off-rates that were 2-and 3-fold faster than the wild-type control.
DISCUSSION
Many lines of evidence indicate that high affinity binding of the R and C subunits of cAPK is a multistep process that requires more than just a linear sequence of R that occupies the active site cleft of the C-subunit. The inhibitor site in R resembles a peptide substrate and presumably binds to the active site of C in a manner similar to the consensus sequence of PKI (15, 17) . This inhibitor site extends from the PϪ3 site to the Pϩ1 site and will be similar for most substrates and inhibitors of cAPK. This site, however, is not sufficient to confer high affinity binding. In addition to the inhibitor recognition site, an additional large surface on C is apparently masked by the R-subunit. This peripheral site on C, referred to here as PRS2, is more complex and will almost certainly depend on the global conformation of the R-subunit. Neither site alone is sufficient for high affinity binding. From the crystal structure of the catalytic subunit we can define the inhibition recognition site very precisely, and, coupled with genetic and mutational mapping, the surface that comprises the peripheral recognition site (PRS2) can be mapped. In contrast to the acidic inhibitor recognition site on C, where the consensus site Arg's dock, the PRS2 surface is very basic.
For the R-subunit, the crystal structure of a deletion mutant (⌬1-91)RI has defined at least some of the structural features that will be recognized by the PRS2 surface on C. Deletion mutants localized most of the essential docking requirements to the A-domain while chemical studies identified specific residues that may be important. Because the R-docking surface on C is very basic, acidic residues in the A-domain of R were specifically targeted. The location of most of these residues in (⌬1-91)RI are shown in Fig. 7A . Each of these residues was replaced with Ala. These mutants will be discussed as three groups. First are those that cluster near the inhibitor site. An additional set of acidic residues were identified by differential labeling with EDC. The third set were identified based on their position on the crystal structure of (⌬1-91)RI.
Glu-101, highly conserved in all R-subunits, lies in the Pϩ4 position just following the inhibitor site. Although this site is not important for R-C interaction in the type I holoenzyme, mutation of this site in both the mammalian and yeast type II R-subunits seriously disrupted holoenzyme formation. The difference in the role of this conserved glutamate in RI and RII highlights that these two types of R-subunit may differ in significant ways in how they interact with C. The interaction of RII and C is potentially much simpler and does not require tight binding of MgATP as does RI and PKI (37) . 6 . Measurement of association and dissociation rate constants for regulatory and catalytic subunits using surface plasmon resonance. Wild-type C-subunit was immobilized and the binding of wild-type or mutant R-subunits were monitored as described under "Experimental Procedures." Panel a, rR(WT); panel b, rR(D170A); panel c, rR(K242A). x axis represents time (in seconds), and y axis represents arbitrary response unit. The concentrations (in nM) used for the various R-subunits were indicated.
TABLE II
Quantitation of interaction between regulatory and catalytic subunits using surface plasmon resonance Surface plasmon resonance was used to determine the association and dissociation rate constants of cAMP-free rR-subunits using a BIAcore instrument with immobilized wild-type C-subunit. Only the late phase (t ϭ 605.5-694.5 s) was used to determine off-rates , in RI was important for binding C; however, the defect exhibited by the triple mutant, rRI(EED/AAA), did not represent an additive effect of each of the single mutants. In fact, rRI(E105A) was the only single-site mutant that was defective in holoenzyme formation. Since the triple mutant resulted in a stronger defect than the single-site E105A mutation, it is likely that an extended negative surface is important for R-C interaction.
In addition to the acidic patch Glu , or to be exposed on the surface where it could interact with another basic residue. Thus, Asp 170 was mutated to Ala to see if this acidic site in the A-domain influenced R-C interactions. Although removal of Asp 170 did not significantly alter the overall affinity for R and C, the D170A mutation resulted in onand off-rates that were both slightly faster than those of wildtype. The faster on-rate in the absence of Asp 170 indicates that Asp 170 may stabilize the cAMP-bound conformation. This constraint would be its interaction with Arg 209 as seen in the crystal structure. Removal of Asp 170 , however, did not alter the affinity for cAMP. Asp 170 may help to stabilize the final holoenzyme conformation as well since the dissociation rate for the mutant protein was also 3-fold faster.
The overall charge on the surface of the A-domain is acidic, however, there is a basic patch on the C-helix of the A-domain that is associated with Lys 242 . The adjacent residue, Arg 241 , is a critical residue for cooperativity between domain A and B (38) . As shown in Fig. 7B , Arg 241 forms hydrogen bonds with residues that reside both in the A-domain (Glu 200 ) and in the B-domain (Asp 267 ). Asp 267 is the only residue in domain B that contributes directly to the hydrogen bond network associated with cAMP binding in site A. Both Arg 241 and Lys 242 lie on the C-helix of domain A, and the orientation of this helix relative to the ␤-barrel will very likely change when cAMP is released. When the structures of domains A and B of (⌬1-91)RI and the nucleotide-binding domain of CAP are superimposed, the most striking difference is the position of the C-helix (16) . In the A-domain, the C-helix is longer, slightly bent and held away from the cAMP pocket. its strong hydrophobic interactions with the C-helix exerts structural constraints on the conformation of the A-domain (16) . The surface of C that is thought to interact with R is mostly basic with the exception of the negative charge associated with the phosphorylated Thr
197
. Lys 242 was thus targeted as a potential electrostatic interaction site for P-T197 in the holoenzyme complex. Like rRI(D170A), rRI(K242A) inhibited rC(WT) in the spectrophotometric inhibition assay without requiring the removal of cAMP by either urea stripping or dialysis. It is unlikely, therefore, that Lys 242 interacts directly with P-T197 on C. Furthermore, as with rRI(D170A), the K242A mutation did not alter either the overall affinity for C or the apparent K a for cAMP activation. Why removal of this Lys actually facilitates R-C interaction is still unclear. To fully understand the precise molecular details of R-C interaction, a crystal structure of the holoenzyme complex is required.
